Dobre, D. et al. (2014) Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering properties. European Journal of Heart Failure, 16(1), pp. 76-85. (doi: 10.1093/eurjhf/hft129) (PMID:23928650)
Full text not currently available from Enlighten.
Abstract
Heart rate not only predicts outcome but may also be a therapeutic target in patients with chronic heart failure. Several classes of pharmacological agents can be used to modulate heart rate, including beta-blockers, ivabradine, digoxin, amiodarone, and verapamil. Choice of agent will depend on heart rhythm, co-morbidities, and disease phenotype. Beneficial and harmful interactions may also exist. The aim of this paper is to summarize the current body of knowledge regarding the relevance of heart rate as a prognostic factor (risk marker) and particularly as a therapeutic target (risk factor) in patients with chronic heart failure, with a special focus on ivabradine, a novel agent that is currently the only available purely bradycardic agent.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Cleland, Professor John |
Authors: | Dobre, D., Borer, J. S., Fox, K., Swedberg, K., Adams, K. F., Cleland, J. G.F., Cohen-Solal, A., Gheorghiade, M., Gueyffier, F., O'Connor, C. M., Fiuzat, M., Patak, A., Piña, I. L., Rosano, G., Sabbah, H. N., Tavazzi, L., and Zannad, F. |
Subjects: | R Medicine > R Medicine (General) |
College/School: | College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > Robertson Centre |
Journal Name: | European Journal of Heart Failure |
ISSN: | 1388-9842 |
ISSN (Online): | 1879-0844 |
Published Online: | 03 December 2013 |
University Staff: Request a correction | Enlighten Editors: Update this record